Preparation of monoclonal antibodies against kinesin for nanotechnology_2
Public support
Provider
Ministry of Education, Youth and Sports
Programme
EUREKA - European co-operation in the sphere of applied and industrial research and development aimed at the support of multinational co-operation among industrial undertakings, research institutes and universities
Call for proposals
EUREKA 1 (SMSM200132005)
Main participants
EXBIO Praha, a.s.
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Příprava monoklonálních protilátek proti kinseinu pro nanotechnologie_2
Annotation in Czech
Příprava vhodných antigenů pro imunizace, konstrukce oanelu hybridomu proti jednotlivým antigenním determinantám kinesinu, výběr vhodných monoklonálních protilátek pro použití v projektu rozvoje nanometrických technik. Chareakteristika protilátek, testování jejich vhodnosti pro různé způsoby výroby, purifikace a skladování. Výroba aprodej protilátek.
Scientific branches
R&D category
—
CEP classification - main branch
FP - Other medical fields
CEP - secondary branch
EC - Immunology
CEP - another secondary branch
EI - Biotechnology and bionics
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30102 - Immunology<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>30501 - Forensic science<br>30502 - Other medical science<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Byly splněny cíle projketu ve stanoveném rozsahu podle zadání v českém návrhu tohoto projektu a stanovené rozhodnutím .Připravené monoklonární protilátky jsou využívány v oblasti studia základních vlastností buňky a jsou dodávány do zahraničí
Solution timeline
Realization period - beginning
Jan 1, 2000
Realization period - end
Jan 1, 2002
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/2003/MSM/MSM3OE/U/N/2:2
Data delivery date
Mar 23, 2004
Finance
Total approved costs
9,188 thou. CZK
Public financial support
2,288 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
6,100 thou. CZK